Seagen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Seagen and buy or sell other stocks, options, and ETFs commission-free!About SGEN
Seattle Genetics is a clinical-stage biotechnology company that focuses on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Its lead product, SGN-35, is in the pivotal trial for patients with relapsed or refractory Hodgkin lymphoma.
CEODavid R. Epstein, MBA
CEODavid R. Epstein, MBA
Employees—
Employees—
HeadquartersBothell, Washington
HeadquartersBothell, Washington
Founded1997
Founded1997
Employees—
Employees—
SGEN Key Statistics
Market cap43.15B
Market cap43.15B
Price-Earnings ratio-57.10
Price-Earnings ratio-57.10
Dividend yield—
Dividend yield—
Average volume3.45M
Average volume3.45M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$228.96
52 Week high$228.96
52 Week low$123.77
52 Week low$123.77